To view this email as a web page, click here.
 
DIABETES DRUGS
 
Top pharmacy challenges of 2017
Earlier this year, we made predictions. Did we get them right?
Read more
 
New diabetes drug set to rival Trulicity
If it is approved by FDA, an investigational drug to improve glycemic control in patients with type 2 diabetes will likely be a strong competitor to Eli Lilly's dulaglutide (Trulicity).
Read more
 
FDA okays unique injectable for type 2 diabetics
FDA approved a once-weekly, single-dose autoinjector device to improve glycemic control in adults with type 2 diabetes.
How it's unique
 
SURVEY
 
Managed Care Technology Survey 2018
Where does your organization stand when it comes to technology use? Help us help you find out by taking our quick survey. You could win a $200 visa gift card.
Take survey
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.